³í¹®) Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms ¼¼ºê¶õ½ºº´¿ø Ç÷¾×Á¾¾ç³»°ú ¹ÎÀ¯È«, Á¤ÁØ¿ø ±³¼ö(»çÁø ÁÂÃø)¿Í Áø´Ü°Ë»çÀÇÇаú ÃÖÁ¾¶ô, À̽ÂÅ ±³¼ö(¿ìÃø) ¿¬±¸ÆÀ